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INTRODUCTION
Langerhans cell sarcoma (LCS) is a neoplastic proliferation
of Langerhans cells that have overtly malignant cytologic fea-
tures (1, 2). It is a very rare disease (2-11) and theoretically,
it can present de novo or it can progress from an antecedent
Langerhans cell histiocytosis (LCH) (1). However, to our know-
ledge, LCS arising from an antecedent LCH has not been
reported on. We present here a case of LCS arising from pul-
monary LCH.
CASE REPORT
The patient was a 34-yr-old man who presented with com-
plaints of fever and a chronic cough. He was a smoker and
had a history of pulmonary tuberculosis that had been treat-
ed and cured. A computed tomographic (CT) scan revealed
multiple tiny nodules in both lungs. A thoracoscopic lung
biopsy was taken from the right upper lobe. The microscopic
examination revealed a typical LCH. The tumor cells had
vesicular and grooved nuclei, and they formed small aggre-
gations around the bronchioles (Fig. 1). The tumor cells were
strongly positive for S-100 protein, vimentin, CD68 and
CD1a. There were infiltrations of lymphocytes and eosinophils
around the tumor cells. With performing additional radio-
logic examinations, no other organs were thought to be in-
volved. He quit smoking, but he received no other specific
treatment. He was well for the following one year. After this,
a follow-up CT scan was performed and it showed a 4 cm-
sized mass in the left lower lobe, in addition to the multiple
tiny nodules in both lungs (Fig. 2). A needle biopsy speci-
men revealed the possibility of a sarcoma; therefore, a lobec-
tomy was performed. 
Grossly, a 4 cm-sized poorly-circumscribed lobulated gray-
white mass was found (Fig. 3), and there were a few small
satellite nodules around the main mass. Microscopically, the
tumor cells were aggregated in large sheets and they showed
an infiltrative growth. The cytologic features of some of the
tumor cells were similar to those seen in a typical LCH. How-
ever, many tumor cells showed overtly malignant cytologic
features such as pleomorphic/hyperchromatic nuclei and pro-
minent nucleoli (Fig. 4), and multinucleated tumor giant
cells were also found. There were numerous mitotic figures
ranging from 30 to 60 per 10 high power fields, and some
of them were abnormal. A few foci of typical LCH remained
around the main tumor mass.
Immunohistochemically, the tumor cells were strongly pos-
itive for S-100 protein (Fig. 5) and vimentin; they were also
positive for CD68 (Dako N1577, Clone KPI), and focally
positive for CD1a (Fig. 6), and they were negative for cytoker-
atin, epithelial membrane antigen, CD3, CD20 and HMB45.
The ultrastructural analysis failed to demonstrate any Bir-
beck granules in the cytoplasm of the tumor cells.
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Langerhans Cell Sarcoma Arising from Langerhans Cell Histiocytosis 
: A Case Report
Langerhans cell sarcoma (LCS) is a neoplastic proliferation of Langerhans cells
that have overtly malignant cytologic features. It is a very rare disease and theoret-
ically, it can present de novo or progress from an antecedent Langerhans cell his-
tiocytosis (LCH). However, to our knowledge, LCS arising from an antecedent LCH
has not been reported on. We present here a case of LCS arising from a pulmonary
LCH. A 34 yr-old man who was a smoker, had a fever and a chronic cough. Com-
puted tomographic (CT) scan revealed multiple tiny nodules in both lungs. The tho-
racoscopic lung biopsy revealed LCH. The patient quit smoking, but he received
no other specific treatment. One year later, the follow up chest CT scan showed a
4 cm-sized mass in the left lower lobe of the lung. A lobectomy was then performed.
Microscopic examination of the mass revealed an infiltrative proliferation of large
cells that had malignant cytologic features. Immunohistochemical stains showed a
strong reactivity for S-100 and CD68, and a focal reactivity for CD1a. We think this
is the first case of LCS arising from LCH. 
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Now, at five months after lobectomy, the patient is doing
well with no significant change in the radiologic findings. 
DISCUSSION 
The clinical spectrum of LCH varies from the indolent
lesion to the more aggressive and often fatal disease. Researches
attempting to relate the histological findings to the progno-
sis have generally been unrewarding (12, 13). Mild atypia
and a high proliferative rate were not always associated with
unfavorable prognosis (12) and these features did not indicate
malignancy. Instead, the prognosis was best predicted by the
clinical parameters. In one report (14), disease free survival
Fig. 1. Langerhans cell histiocytosis. Many tumor cells show gro-
oved nuclei. There is an infiltration of lymphocytes and eosinophils
around the tumor cells (H-E stain, ×200).
Fig. 2. A CT scan shows multiple tiny nodules in both lungs and a
lobulated mass in the left lower lobe. 
Fig. 3. The tumor is poorly circumscribed and has a gray white
cut surface. 
Fig. 4. Langerhans cell sarcoma. The tumor cells are highly pleo-
morphic and many tumor cells have hyperchromatic nuclei. There
are infiltrations of neutrophils and eosinphils around the tumor cells
(H-E stain, ×200).Langerhans Cell Sarcoma  579
was achieved in all the patients having isolated bone lesions.
By contrast, 20% of the patients with multisystem involve-
ment had a progressive disease course despite extensive treat-
ment. However, the marked atypia was generally associated
with an aggressive clinical course and distant metastasis (2-
6, 9-11). Therefore, the cases of LCH with markedly atypi-
cal tumor cells should be called LCS, and these cases should
be considered as a separate entity apart from LCH (1, 2, 9).
Langerhans cell sarcoma is an exceedingly rare cancer, and
we found only 18 cases in the English-language literature.
These were 9 cases (7 cases had aggressive clinical course and
2 cases had a benign clinical course.) reported on by Ben-Ezra
et al. (2), and 9 isolated cases (3-11). Of the 19 cases, includ-
ing our case, the skin was involved at the time of diagnosis in
9 cases, and the skin was the only organ involved in 3 of the
cases. The lymph nodes, spleen, liver, bone marrow, thymus,
lung and kidney were the other organs frequently involved.
The heart was involved in two cases (2, 3). The age at the
time of diagnosis ranged from newborn (2) to 76 yr (7) with
the average age being 37. Eleven patients were male and 8
were female. Of the 19 patients, 11 died within 2 yr, and one
died at 40 months. Of the remaining 8 patients who survived
their disease, the skin was the only organ involved in 3 pati-
ents, and 4 of the patients had been followed-up for less than
1 yr.
Tani et al. (9) suggested the following criteria for the diag-
nosis of malignant neoplasm of Langerhans cells: 1) prolifer-
ation of the typical Birbeck granule-containing tumor cells,
and 2) such malignant cytological features as atypia and fre-
quent mitotic figures. Although we could not demonstrate
Birbeck granules, we were not dissuaded from making the
diagnosis of LCS. Cells may lose their ultrastructural charac-
teristics or their immunophenotype as they become less dif-
ferentiated and more atypical. In fact, Ben-Ezra et al. (2) could
demonstrate Birbeck granules in only 3 of the nine cases they
reported on. Histiocytic sarcoma and other dendritic cell
tumors should be included in the differential diagnoses. These
tumors were excluded because our case was focally, yet defi-
nitely positive for CD1a (15, 16).
It has been said that LCS can present de novo or progress
from an antecedent LCH (1). However, to our knowledge,
LCS arising from an antecedent LCH has not been reported
on. Two of the patients reported on by Ben-Ezra et al. (2) had
benign Langerhans cells in one organ, and they had atypical
ones in other organs. However, the tumors arose from different
organs and the relation between the tumors was not stated.
We think our case is the first case of LCS arising from LCH
in that 1) it was preceded by a typical LCH in the same organ,
2) the tumor cells were markedly atypical, but they had some
features of LCH remaining, and 3) the tumor cells were posi-
tive for S-100 protein, CD68 and CD1a. 
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